BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

939 related articles for article (PubMed ID: 18363884)

  • 1. Randomized controlled GH trial: effects on anthropometry, body composition and body proportions in a large group of children with Prader-Willi syndrome.
    Festen DA; de Lind van Wijngaarden R; van Eekelen M; Otten BJ; Wit JM; Duivenvoorden HJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):443-51. PubMed ID: 18363884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained benefit after 2 years of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome.
    Myers SE; Carrel AL; Whitman BY; Allen DB
    J Pediatr; 2000 Jul; 137(1):42-9. PubMed ID: 10891820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone treatment completely normalizes adult height and improves body composition in Prader-Willi syndrome: experience from KIGS (Pfizer International Growth Database).
    Lindgren AC; Lindberg A
    Horm Res; 2008; 70(3):182-7. PubMed ID: 18663319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective study of the potential benefits and adverse events during growth hormone treatment in children with Prader-Willi syndrome.
    Fillion M; Deal C; Van Vliet G
    J Pediatr; 2009 Feb; 154(2):230-3. PubMed ID: 18814886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effects of growth hormone (GH) treatment on body composition and bone mineral density in short children born small-for-gestational-age: six-year follow-up of a randomized controlled GH trial.
    Willemsen RH; Arends NJ; Bakker-van Waarde WM; Jansen M; van Mil EG; Mulder J; Odink RJ; Reeser M; Rongen-Westerlaken C; Stokvis-Brantsma WH; Waelkens JJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):485-92. PubMed ID: 17561977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone improves mobility and body composition in infants and toddlers with Prader-Willi syndrome.
    Carrel AL; Moerchen V; Myers SE; Bekx MT; Whitman BY; Allen DB
    J Pediatr; 2004 Dec; 145(6):744-9. PubMed ID: 15580194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mental and motor development before and during growth hormone treatment in infants and toddlers with Prader-Willi syndrome.
    Festen DA; Wevers M; Lindgren AC; Böhm B; Otten BJ; Wit JM; Duivenvoorden HJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2008 Jun; 68(6):919-25. PubMed ID: 18031326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone treatment and adverse events in Prader-Willi syndrome: data from KIGS (the Pfizer International Growth Database).
    Craig ME; Cowell CT; Larsson P; Zipf WB; Reiter EO; Albertsson Wikland K; Ranke MB; Price DA;
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):178-85. PubMed ID: 16886957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
    Högler W; Briody J; Moore B; Lu PW; Cowell CT
    Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone and body composition in children younger than 2 years with Prader-Willi syndrome.
    Eiholzer U; L'allemand D; Schlumpf M; Rousson V; Gasser T; Fusch C
    J Pediatr; 2004 Jun; 144(6):753-8. PubMed ID: 15192622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of growth hormone on whole body and regional soft tissue composition in adult patients on hemodialysis. A double-blind, randomized, placebo-controlled study.
    Hansen TB; Gram J; Jensen PB; Kristiansen JH; Ekelund B; Christiansen JS; Pedersen FB
    Clin Nephrol; 2000 Feb; 53(2):99-107. PubMed ID: 10711411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid hormone levels in children with Prader-Willi syndrome before and during growth hormone treatment.
    Festen DA; Visser TJ; Otten BJ; Wit JM; Duivenvoorden HJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2007 Sep; 67(3):449-56. PubMed ID: 17716335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone treatment for two years is safe and effective in adults with Prader-Willi syndrome.
    Sode-Carlsen R; Farholt S; Rabben KF; Bollerslev J; Schreiner T; Jurik AG; Frystyk J; Christiansen JS; Höybye C
    Growth Horm IGF Res; 2011 Aug; 21(4):185-90. PubMed ID: 21664161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of growth hormone therapy on glucose metabolism and insulin sensitivity indices in prepubertal children with Prader-Willi syndrome.
    Crinò A; Di Giorgio G; Manco M; Grugni G; Maggioni A
    Horm Res; 2007; 68(2):83-90. PubMed ID: 17337902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GH treatment and its effect on bone mineral density, bone maturation and growth in short children born small for gestational age: 3-year results of a randomized, controlled GH trial.
    Arends NJ; Boonstra VH; Mulder PG; Odink RJ; Stokvis-Brantsma WH; Rongen-Westerlaken C; Mulder JC; Delemarre-Van de Waal H; Reeser HM; Jansen M; Waelkens JJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):779-87. PubMed ID: 14974922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of long-term continuous growth hormone treatment in children with Prader-Willi syndrome.
    de Lind van Wijngaarden RF; Siemensma EP; Festen DA; Otten BJ; van Mil EG; Rotteveel J; Odink RJ; Bindels-de Heus GC; van Leeuwen M; Haring DA; Bocca G; Houdijk EC; Hoorweg-Nijman JJ; Vreuls RC; Jira PE; van Trotsenburg AS; Bakker B; Schroor EJ; Pilon JW; Wit JM; Drop SL; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2009 Nov; 94(11):4205-15. PubMed ID: 19837938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary Energy Intake, Body Composition and Resting Energy Expenditure in Prepubertal Children with Prader-Willi Syndrome before and during Growth Hormone Treatment: A Randomized Controlled Trial.
    Bakker NE; Siemensma EP; Koopman C; Hokken-Koelega AC
    Horm Res Paediatr; 2015; 83(5):321-31. PubMed ID: 25764996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone induced lipolysis during short- and long-term administration in adult Prader-Willi patients.
    Höybye C; Hilding A; Marcus C; Thorén M
    Growth Horm IGF Res; 2005 Dec; 15(6):411-5. PubMed ID: 16230042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Head circumference and body proportions before and during growth hormone treatment in short children who were born small for gestational age.
    Arends NJ; Boonstra VH; Hokken-Koelega AC
    Pediatrics; 2004 Sep; 114(3):683-90. PubMed ID: 15342839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early manifestations of Prader-Willi syndrome: influence of growth hormone.
    Eiholzer U; Schlumpf M; Nordmann Y; l'Allemand D
    J Pediatr Endocrinol Metab; 2001; 14 Suppl 6():1441-4. PubMed ID: 11837497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.